Meeder Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $104K | Buy |
1,838
+75
| +4% | +$4.37K | 0.01% | 359 |
|
|
2025
Q4 | $105K | Buy |
1,763
+1,678
| +1,974% | +$91.4K | 0.01% | 327 |
|
|
2025
Q3 | $4.6K | Buy |
85
+9
| +12% | +$515 | ﹤0.01% | 689 |
|
|
2025
Q2 | $4.18K | Buy |
76
+28
| +58% | +$1.65K | ﹤0.01% | 739 |
|
|
2025
Q1 | $3.39K | Buy |
+48
| New | +$3.23K | ﹤0.01% | 820 |
|
|
2024
Q4 | – | Sell |
-735
| Closed | -$51.7K | – | 915 |
|
|
2024
Q3 | $51.7K | Buy |
735
+663
| +921% | +$55.4K | ﹤0.01% | 363 |
|
|
2024
Q2 | $5.93K | Sell |
72
-6
| -8% | -$500 | ﹤0.01% | 753 |
|
|
2024
Q1 | $6.81K | Buy |
+78
| New | +$6.98K | ﹤0.01% | 605 |
|
|
2023
Q1 | – | Sell |
-4
| Closed | -$414 | – | 629 |
|
|
2022
Q4 | $414 | Buy |
+4
| New | +$376 | ﹤0.01% | 754 |
|
|
2022
Q2 | – | Sell |
-37
| Closed | -$3K | – | 2183 |
|
|
2022
Q1 | $3K | Buy |
+37
| New | +$3.1K | ﹤0.01% | 1918 |
|
|
2021
Q4 | – | Sell |
-46
| Closed | -$4K | – | 1305 |
|
|
2021
Q3 | $4K | Sell |
46
-22
| -32% | -$1.74K | ﹤0.01% | 1978 |
|
|
2021
Q2 | $6K | Hold |
68
| – | – | ﹤0.01% | 1863 |
|
|
2021
Q1 | $5K | Sell |
68
-25
| -27% | -$2.04K | ﹤0.01% | 1844 |
|
|
2020
Q4 | $8K | Sell |
93
-51
| -35% | -$4.04K | ﹤0.01% | 1052 |
|
|
2020
Q3 | $11K | Sell |
144
-16,295
| -99% | -$1.65M | ﹤0.01% | 1333 |
|
|
2020
Q2 | $2.03M | Buy |
16,439
+13,965
| +564% | +$1.39M | 0.13% | 140 |
|
|
2020
Q1 | $208K | Buy |
2,474
+238
| +11% | +$20.5K | 0.02% | 559 |
|
|
2019
Q4 | $189K | Buy |
2,236
+1,828
| +448% | +$138K | 0.01% | 618 |
|
|
2019
Q3 | $27K | Buy |
408
+173
| +74% | +$13.3K | ﹤0.01% | 1207 |
|
|
2019
Q2 | $20K | Buy |
+235
| New | +$20.1K | ﹤0.01% | 1230 |
|
|
2019
Q1 | – | Sell |
-211
| Closed | -$18K | – | 1704 |
|
|
2018
Q4 | $18K | Sell |
211
-279
| -57% | -$26.5K | ﹤0.01% | 1088 |
|
|
2018
Q3 | $48K | Hold |
490
| – | – | ﹤0.01% | 792 |
|
|
2018
Q2 | $46.2K | Sell |
490
-37
| -7% | -$3.24K | ﹤0.01% | 776 |
|
|
2018
Q1 | $43K | Hold |
527
| – | – | ﹤0.01% | 709 |
|
|
2017
Q4 | $47K | Sell |
527
-309
| -37% | -$26.9K | ﹤0.01% | 707 |
|
|
2017
Q3 | $78K | Buy |
+836
| New | +$73.9K | 0.01% | 610 |
|
|
2016
Q4 | – | Sell |
-1,194
| Closed | -$110K | – | 983 |
|
|
2016
Q3 | $110K | Sell |
1,194
-605
| -34% | -$57K | 0.01% | 593 |
|
|
2016
Q2 | $140K | Buy |
+1,799
| New | +$153K | 0.01% | 621 |
|
|
2016
Q1 | – | Sell |
-1,066
| Closed | -$112K | – | 847 |
|
|
2015
Q4 | $112K | Buy |
1,066
+375
| +54% | +$39.2K | 0.01% | 613 |
|
|
2015
Q3 | $73K | Buy |
+691
| New | +$92.3K | 0.01% | 614 |
|
Other funds holding BMRN
VCM
VPM
